Search

Walter E. Webb

Examiner (ID: 8444, Phone: (571)270-3287 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
4133, 1612
Total Applications
1244
Issued Applications
565
Pending Applications
114
Abandoned Applications
592

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7111750 [patent_doc_number] => 20050209206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier' [patent_app_type] => utility [patent_app_number] => 10/503000 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10940 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209206.pdf [firstpage_image] =>[orig_patent_app_number] => 10503000 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503000
Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier Feb 3, 2003 Abandoned
Array ( [id] => 7200332 [patent_doc_number] => 20050164996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions' [patent_app_type] => utility [patent_app_number] => 10/502902 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9577 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164996.pdf [firstpage_image] =>[orig_patent_app_number] => 10502902 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/502902
Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions Feb 3, 2003 Abandoned
Array ( [id] => 239612 [patent_doc_number] => 07592329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Crystalline complexes of fluticasone-2-furoate' [patent_app_type] => utility [patent_app_number] => 10/503114 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 23501 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592329.pdf [firstpage_image] =>[orig_patent_app_number] => 10503114 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503114
Crystalline complexes of fluticasone-2-furoate Feb 3, 2003 Issued
Array ( [id] => 6982775 [patent_doc_number] => 20050152845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form' [patent_app_type] => utility [patent_app_number] => 10/503394 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12737 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152845.pdf [firstpage_image] =>[orig_patent_app_number] => 10503394 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503394
Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form Feb 3, 2003 Abandoned
Array ( [id] => 7020088 [patent_doc_number] => 20050222107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Novel process' [patent_app_type] => utility [patent_app_number] => 10/502866 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8949 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222107.pdf [firstpage_image] =>[orig_patent_app_number] => 10502866 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/502866
Novel process Feb 2, 2003 Abandoned
Array ( [id] => 7256710 [patent_doc_number] => 20050143388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Nitric oxide donors for treatment of disease and injury' [patent_app_type] => utility [patent_app_number] => 10/500694 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18515 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143388.pdf [firstpage_image] =>[orig_patent_app_number] => 10500694 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/500694
Nitric oxide donors for treatment of disease and injury Jan 5, 2003 Abandoned
Array ( [id] => 5700630 [patent_doc_number] => 20060217315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method' [patent_app_type] => utility [patent_app_number] => 10/499505 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6510 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217315.pdf [firstpage_image] =>[orig_patent_app_number] => 10499505 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/499505
Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method Dec 19, 2002 Abandoned
Array ( [id] => 5814823 [patent_doc_number] => 20060084612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors' [patent_app_type] => utility [patent_app_number] => 10/500606 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2298 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084612.pdf [firstpage_image] =>[orig_patent_app_number] => 10500606 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/500606
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors Dec 17, 2002 Abandoned
Array ( [id] => 4697751 [patent_doc_number] => 20080219935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Phase Transitive Breath Care Products' [patent_app_type] => utility [patent_app_number] => 11/994970 [patent_app_country] => US [patent_app_date] => 2002-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5149 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219935.pdf [firstpage_image] =>[orig_patent_app_number] => 11994970 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/994970
Phase Transitive Breath Care Products Jul 6, 2002 Abandoned
Array ( [id] => 4566511 [patent_doc_number] => 07846957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Aromatase inhibition to enhance assisted reproduction' [patent_app_type] => utility [patent_app_number] => 10/475172 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14744 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846957.pdf [firstpage_image] =>[orig_patent_app_number] => 10475172 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/475172
Aromatase inhibition to enhance assisted reproduction Apr 16, 2002 Issued
Array ( [id] => 7151271 [patent_doc_number] => 20040171660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Single dose aromatase inhibitor for treating infertility' [patent_app_type] => new [patent_app_number] => 10/475101 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15260 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 65 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171660.pdf [firstpage_image] =>[orig_patent_app_number] => 10475101 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/475101
Single dose aromatase inhibitor for treating infertility Apr 16, 2002 Issued
Array ( [id] => 7004684 [patent_doc_number] => 20050169997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Method for preparing resinates' [patent_app_type] => utility [patent_app_number] => 10/501765 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6396 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169997.pdf [firstpage_image] =>[orig_patent_app_number] => 10501765 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/501765
Method for preparing resinates Jan 17, 2002 Abandoned
Array ( [id] => 5632262 [patent_doc_number] => 20060148732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Inhibition of NF-kappaB by triterpene compositions' [patent_app_type] => utility [patent_app_number] => 09/992556 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 87518 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148732.pdf [firstpage_image] =>[orig_patent_app_number] => 09992556 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/992556
Inhibition of NF-kappaB by triterpene compositions Nov 15, 2001 Abandoned
Menu